Merck & Co (NY:MRK)

107.40 -0.78 (-0.72%)

Official Closing Price Updated: 4:10 PM EST, Jan 26, 2026 Add to My Watchlist

Price and Volume

Volume	9,802,639
Open	107.80
Bid (Size)	107.09 (100)
Ask (Size)	108.00 (300)
Prev. Close	108.18
Today's Range	107.06 - 108.42
52wk Range	73.31 - 112.90
Shares Outstanding	2,531,374,696
Dividend Yield	3.17%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape

Today 10:27 EST

As of January 26, 2026, Merck & Co. (NYSE: MRK) stands at the most critical juncture in its 135-year history. Known globally for its dominant oncology franchise and robust vaccine portfolio, the...

Via Finterra

The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed

Today 9:41 EST

The biotechnology sector has always been a high-stakes arena where clinical success can create multi-billion-dollar empires overnight, and a failed negotiation can erase a fifth of a company’s market...

Via Finterra

Performance

YTD	+0.9%	+0.9%
1 Month	+0.6%	+0.6%
3 Month	+22.0%	+22.0%
6 Month	+27.8%	+27.8%
1 Year	+9.7%	+9.7%

More News

Merck & Co. Inc. (NYSE:MRK) Stands Out as a High-Quality Dividend Stock ↗

January 24, 2026

Via Chartmill

MRNA Vs NVAX: Which Vaccine Stock Is Wall Street More Bullish On Right Now? ↗

January 21, 2026

Via Stocktwits

Revolution Medicines Stock Sinks After Merck Deal Talks Collapse ↗

Today 6:01 EST

Via Benzinga

Nasdaq, S&P 500 Futures Open The Week On Edge As Earnings, Tariffs, Fed Decision Loom: Why META, NVDA, RVMD, USAR Are On Traders' Radar Today ↗

Today 3:22 EST

Via Stocktwits

Revolution Medicines Stock Stares At Big Dip After Merck Reportedly Shelves Buyout — But Analyst Flags Opportunity ↗

Today 1:56 EST

Via Stocktwits

2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗

January 24, 2026

Via The Motley Fool

2 Dirt Cheap Stocks to Buy With $200 Right Now ↗

January 24, 2026

Via The Motley Fool

Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? ↗

January 23, 2026

Via The Motley Fool

2 Soaring Stocks to Hold for the Next 20 Years ↗

January 23, 2026

Via The Motley Fool

Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026

January 23, 2026

Via MarketMinute

I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026. ↗

January 22, 2026

Via The Motley Fool

Moderna and Merck Solidify Oncology Leadership as Five-Year Melanoma Data Fuels Market Rally

January 22, 2026

Via MarketMinute

Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth

January 22, 2026

Via MarketMinute

Moderna’s 2026 Pivot: From Pandemic Pioneer to Oncology Powerhouse

January 22, 2026

Via Finterra

2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm

January 21, 2026

Via StockStory

Why Moderna Stock Surged Today ↗

January 21, 2026

Via The Motley Fool

Merck Shares Rise On $30M Funding From CEPI To Develop Affordable Ebola Vaccine ↗

January 21, 2026

Via Stocktwits

Moderna Stock Still Worth 37% Less After Cancer Vaccine Data? BofA’s New Price Target Keeps Retail Traders Cautious ↗

January 20, 2026

Via Stocktwits

Moderna Shares Rise On Five-Year Follow-Up Takeaways For Skin Cancer Vaccine: Retail Applauds ‘Solid’ Update ↗

January 20, 2026

Via Stocktwits

GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics

January 20, 2026

Via MarketMinute

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following

January 20, 2026

Via ACCESS Newswire

3 “Forever Stocks” to Hold When the Market Won’t Sit Still ↗

January 19, 2026

Via MarketBeat

The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature

January 19, 2026

Via Finterra

Frequently Asked Questions

Is Merck & Co publicly traded?

Yes, Merck & Co is publicly traded.

What exchange does Merck & Co trade on?

Merck & Co trades on the New York Stock Exchange

What is the ticker symbol for Merck & Co?

The ticker symbol for Merck & Co is MRK on the New York Stock Exchange

What is the current price of Merck & Co?

The current price of Merck & Co is 107.40

When was Merck & Co last traded?

The last trade of Merck & Co was at 01/26/26 04:10 PM ET

What is the market capitalization of Merck & Co?

The market capitalization of Merck & Co is 271.87B

How many shares of Merck & Co are outstanding?

Merck & Co has 272B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.